Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

New Research in Hebrew Language and Culture

2014-01-17

The newly formed Department of Hebrew at the university is hosting an international conference from 27 to 29 January 2014. The conference has speakers from Israel, the United States, Canada, the United Kingdom and Saudi Arabia, as well as South Africa, Zambia, Congo and Nigeria. The goal of the conference is to highlight recent research in Hebrew language and culture by bringing international scholarship to the university and by highlighting the importance of the African context as a conceptual space for research on Hebrew. The rich cultural heritage of Hebrew finds particular resonance in Africa through the Hebrew Bible (Old Testament).

Some highlights from the conference include new research on the use of the ancient Hebrew script by Jews in the Persian and Roman periods as a means to maintain their religious and ethnic identity in times of distress, linguistic research on metaphors in the Hebrew Bible (Old Testament), Jews and non-Jews in the Hebrew and Yiddish writings of the South African author Morris Hoffman, the development of a rabbinic prayer for rain in the land of Israel and in South Africa, pedagogical advances in teaching Hebrew in Africa, and translation of the Hebrew Bible (Old Testament) as a means of reshaping VaTsonga cultural identity.

The study of ancient and modern Hebrew language and culture provides important insights into the complex cultural situation in modern Africa, generally, and South Africa, in particular. The use of language by minority religious and ethnic groups can provide a powerful force for identity in turbulent political realities. Religious texts can be re-contextualised to provide guidance in new cultural contexts or translated to enhance and empower local societies.

Venue: CR Swart Auditorium

For more information, contact Prof Cynthia Miller-Naudé, Head of the Department of Hebrew at millercl@ufs.ac.za .

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept